SG Americas Securities LLC Acquires 69,215 Shares of ARK Genomic Revolution ETF $ARKG

SG Americas Securities LLC boosted its stake in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 207.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 102,521 shares of the company’s stock after buying an additional 69,215 shares during the period. SG Americas Securities LLC owned approximately 0.23% of ARK Genomic Revolution ETF worth $2,970,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of ARKG. Krilogy Financial LLC bought a new stake in shares of ARK Genomic Revolution ETF during the third quarter worth $5,806,000. Jump Financial LLC bought a new stake in ARK Genomic Revolution ETF in the 3rd quarter valued at $4,563,000. NTV Asset Management LLC bought a new stake in ARK Genomic Revolution ETF in the 3rd quarter valued at $4,449,000. Group One Trading LLC acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter worth $2,274,000. Finally, Woodline Partners LP acquired a new position in ARK Genomic Revolution ETF in the 3rd quarter worth $2,071,000.

ARK Genomic Revolution ETF Stock Performance

ARKG stock opened at $27.36 on Friday. The stock has a 50-day moving average price of $28.43 and a two-hundred day moving average price of $29.43. ARK Genomic Revolution ETF has a 1 year low of $17.50 and a 1 year high of $34.39.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.